Exeliom Biosciences
Developer of immunotherapies designed to help harness the therapeutic potential of gut microbiota. The company develops single bacterial strain drug candidates to deliver microbiome-based immunotherap...
Valuation
$0
Share Price
N/A
Total Raised
$33.3M
Last Round
N/A